{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:39:29Z","timestamp":1792633169519,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Traditional Chinese Medicine Research Project of Hubei Administration of Traditional Chinese Medicine","award":["Grant No. ZY2023F033"],"award-info":[{"award-number":["Grant No. ZY2023F033"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-06337-z","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T01:17:03Z","timestamp":1784942223000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inflammation-based phenotyping and prognostic implications in patients with non-obstructive coronary artery disease"],"prefix":"10.1186","volume":"26","author":[{"given":"Yutao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruobin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"issue":"10053","key":"6337_CR1","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","volume":"388","author":"GBD 2015 Mortality and Causes of Death Collaborators","year":"2016","unstructured":"GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459\u2013544.","journal-title":"Lancet"},{"issue":"4","key":"6337_CR2","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1001\/jama.293.4.477","volume":"293","author":"R Bugiardini","year":"2005","unstructured":"Bugiardini R, Merz CNB. Angina with normal coronary arteries: a changing philosophy. JAMA. 2005;293(4):477\u201384.","journal-title":"JAMA"},{"issue":"10","key":"6337_CR3","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1056\/NEJMoa0907272","volume":"362","author":"MR Patel","year":"2010","unstructured":"Patel MR, Peterson ED, Dai D, Brennan JM, Redberg RF, Anderson HV, Brindis RG, Douglas PS. Low diagnostic yield of elective coronary angiography. N Engl J Med. 2010;362(10):886\u201395.","journal-title":"N Engl J Med"},{"issue":"2","key":"6337_CR4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.15420\/icr.2019.04.R1","volume":"14","author":"TJ Ford","year":"2019","unstructured":"Ford TJ, Berry C. How to Diagnose and Manage Angina Without Obstructive Coronary Artery Disease: Lessons from the British Heart Foundation CorMicA Trial. Interv Cardiol. 2019;14(2):76\u201382.","journal-title":"Interv Cardiol"},{"issue":"6","key":"6337_CR5","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/eurheartj\/ehr331","volume":"33","author":"L Jespersen","year":"2012","unstructured":"Jespersen L, Hvelplund A, Abildstr\u00f8m SZ, et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J. 2012;33(6):734\u201344.","journal-title":"Eur Heart J"},{"issue":"11","key":"6337_CR6","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.116.024534","volume":"135","author":"CNB Merz","year":"2017","unstructured":"Merz CNB, Pepine CJ, Walsh MN, Fleg JL. Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade. Circulation. 2017;135(11):1075\u201392.","journal-title":"Circulation"},{"issue":"36","key":"6337_CR7","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"V Christiaan","year":"2024","unstructured":"Christiaan V, Felicita A, Koskinas Konstantinos C, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45(36):3415\u2013537.","journal-title":"Eur Heart J"},{"issue":"15","key":"6337_CR8","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1056\/NEJMoa1916370","volume":"382","author":"JA Spertus","year":"2020","unstructured":"Spertus JA, Jones PG, Maron DJ, et al. Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease. N Engl J Med. 2020;382(15):1408\u201319.","journal-title":"N Engl J Med"},{"issue":"4","key":"6337_CR9","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.numecd.2013.09.021","volume":"24","author":"F Tona","year":"2014","unstructured":"Tona F, Serra R, Ascenzo LD, et al. Systemic inflammation is related to coronary microvascular dysfunction in obese patients without obstructive coronary disease. Nutr Metab Cardiovasc Dis. 2014;24(4):447\u201353.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"12","key":"6337_CR10","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med. 2017;377(12):1119\u201331.","journal-title":"N Engl J Med"},{"issue":"11","key":"6337_CR11","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1080\/14779072.2025.2564137","volume":"23","author":"I Antonino","year":"2025","unstructured":"Antonino I, Antonio G, Davide C. Anti-inflammatory strategies for patients with atherosclerotic coronary disease. Expert Rev Cardiovasc Ther. 2025;23(11):703\u201321.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"15","key":"6337_CR12","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.jacc.2025.07.064","volume":"86","author":"A Imbesi","year":"2025","unstructured":"Imbesi A, Greco A, Spagnolo M, et al. Targeting Inflammation After Acute Myocardial Infarction. J Am Coll Cardiol. 2025;86(15):1146\u201369.","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"6337_CR13","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1016\/j.jacc.2018.09.042","volume":"72","author":"VR Taqueti","year":"2018","unstructured":"Taqueti VR, Carli MFD. Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options: JACC State-of-the-Art Review. J Am Coll Cardiol. 2018;72(21):2625\u201341.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"6337_CR14","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1161\/CIRCRESAHA.118.311098","volume":"124","author":"P Libby","year":"2019","unstructured":"Libby P, Pasterkamp G, Crea F, Jang I. Reassessing the Mechanisms of Acute Coronary Syndromes. Circ Res. 2019;124(1):150\u201360.","journal-title":"Circ Res"},{"issue":"25","key":"6337_CR15","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1161\/CIRCULATIONAHA.118.034365","volume":"137","author":"DM Herrington","year":"2018","unstructured":"Herrington DM, Mao C, Parker SJ, et al. Proteomic Architecture of Human Coronary and Aortic Atherosclerosis. Circulation. 2018;137(25):2741\u201356.","journal-title":"Circulation"},{"key":"6337_CR16","first-page":"100370","volume":"24","author":"J Schroder","year":"2019","unstructured":"Schroder J, Mygind ND, Frestad D, et al. Pro-inflammatory biomarkers in women with non-obstructive angina pectoris and coronary microvascular dysfunction. Int J Cardiol Heart Vasc. 2019;24:100370.","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"1","key":"6337_CR17","doi-asserted-by":"publisher","first-page":"10566","DOI":"10.1038\/s41598-018-28646-w","volume":"8","author":"J Fest","year":"2018","unstructured":"Fest J, Ruiter R, Ikram MA, Voortman T, van Eijck CHJ, Stricker BH. Reference values for white blood-cell-based inflammatory markers in the Rotterdam Study: a population-based prospective cohort study. Sci Rep. 2018;8(1):10566.","journal-title":"Sci Rep"},{"key":"6337_CR18","doi-asserted-by":"publisher","first-page":"1248655","DOI":"10.3389\/fcvm.2023.1248655","volume":"10","author":"X Wei","year":"2023","unstructured":"Wei X, Zhang Z, Wei J, Luo C. Association of systemic immune inflammation index and system inflammation response index with clinical risk of acute myocardial infarction. Front Cardiovasc Med. 2023;10:1248655.","journal-title":"Front Cardiovasc Med"},{"key":"6337_CR19","doi-asserted-by":"publisher","first-page":"1367919","DOI":"10.3389\/fcvm.2024.1367919","volume":"11","author":"H Zhou","year":"2024","unstructured":"Zhou H, Li X, Wang W, Zha Y, Gao G, Li S, Liu B, Guo R. Immune-inflammatory biomarkers for the occurrence of MACE in patients with myocardial infarction with non-obstructive coronary arteries. Front Cardiovasc Med. 2024;11:1367919.","journal-title":"Front Cardiovasc Med"},{"key":"6337_CR20","doi-asserted-by":"publisher","first-page":"112860","DOI":"10.1016\/j.intimp.2024.112860","volume":"141","author":"H Ji","year":"2024","unstructured":"Ji H, Luo Z, Ye L, et al. Prognostic significance of C-reactive protein-albumin-lymphocyte (CALLY) index after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Int Immunopharmacol. 2024;141:112860.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"6337_CR21","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.114.010637","volume":"131","author":"SJ Shah","year":"2015","unstructured":"Shah SJ, Katz DH, Selvaraj S, et al. Phenomapping for novel classification of heart failure with preserved ejection fraction. Circulation. 2015;131(3):269\u201379.","journal-title":"Circulation"},{"issue":"1","key":"6337_CR22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1001\/jamacardio.2017.4665","volume":"3","author":"T Inohara","year":"2018","unstructured":"Inohara T, Shrader P, Pieper K, et al. Association of of Atrial Fibrillation Clinical Phenotypes With Treatment Patterns and Outcomes: A Multicenter Registry Study. JAMA Cardiol. 2018;3(1):54\u201363.","journal-title":"JAMA Cardiol"},{"issue":"12","key":"6337_CR23","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1161\/CIRCULATIONAHA.117.029870","volume":"136","author":"F Crea","year":"2017","unstructured":"Crea F, Libby P. Acute Coronary Syndromes: The Way Forward From Mechanisms to Precision Treatment. Circulation. 2017;136(12):1155\u201366.","journal-title":"Circulation"},{"key":"6337_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ijcard.2017.08.068","volume":"250","author":"P Ong","year":"2018","unstructured":"Ong P, Camici PG, Beltrame JF, et al. International standardization of diagnostic criteria for microvascular angina. Int J Cardiol. 2018;250:16\u201320.","journal-title":"Int J Cardiol"},{"issue":"23 Pt A","key":"6337_CR25","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1016\/j.jacc.2018.09.006","volume":"72","author":"TJ Ford","year":"2018","unstructured":"Ford TJ, Stanley B, Good R, et al. Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina: The CorMicA Trial. J Am Coll Cardiol. 2018;72(23 Pt A):2841\u201355.","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"6337_CR26","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1016\/j.jacc.2010.01.054","volume":"55","author":"CJ Pepine","year":"2010","unstructured":"Pepine CJ, Anderson RD, Sharaf BL, et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women\u2019s Ischemia Syndrome Evaluation) study. J Am Coll Cardiol. 2010;55(25):2825\u201332.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"6337_CR27","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1161\/CIRCULATIONAHA.116.023266","volume":"135","author":"VR Taqueti","year":"2017","unstructured":"Taqueti VR, Shaw LJ, Cook NR, et al. Excess Cardiovascular Risk in Women Relative to Men Referred for Coronary Angiography Is Associated With Severely Impaired Coronary Flow Reserve, Not Obstructive Disease. Circulation. 2017;135(6):566\u201377.","journal-title":"Circulation"},{"issue":"6","key":"6337_CR28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11906-022-01183-8","volume":"24","author":"PJ Connelly","year":"2022","unstructured":"Connelly PJ, Currie G, Delles C. Sex Differences in the Prevalence, Outcomes and Management of Hypertension. Curr Hypertens Rep. 2022;24(6):185\u201392.","journal-title":"Curr Hypertens Rep"},{"key":"6337_CR29","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","volume":"908","author":"C Franceschi","year":"2000","unstructured":"Franceschi C, Bonaf\u00e8 M, Valensin S, Olivieri F, De Luca M, Ottaviani E, De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244\u201354.","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"6337_CR30","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1093\/cvr\/cvae240","volume":"121","author":"JF Aranda","year":"2025","unstructured":"Aranda JF, Ram\u00edrez CM, Mittelbrunn M. Inflammageing, a targetable pathway for preventing cardiovascular diseases. Cardiovasc Res. 2025;121(10):1537\u201350.","journal-title":"Cardiovasc Res"},{"issue":"23","key":"6337_CR31","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","volume":"54","author":"P Libby","year":"2009","unstructured":"Libby P, Ridker PM, Hansson GK. null. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009;54(23):2129\u201338.","journal-title":"J Am Coll Cardiol"},{"issue":"7121","key":"6337_CR32","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860\u20137.","journal-title":"Nature"},{"issue":"5","key":"6337_CR33","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.jaci.2005.02.023","volume":"115","author":"G Fantuzzi","year":"2005","unstructured":"Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol. 2005;115(5):911\u20139. quiz 920.","journal-title":"J Allergy Clin Immunol"},{"issue":"1\u20133","key":"6337_CR34","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1159\/000368940","volume":"39","author":"OM Akchurin","year":"2015","unstructured":"Akchurin OM, Kaskel F. Update on inflammation in chronic kidney disease. Blood Purif. 2015;39(1\u20133):84\u201392.","journal-title":"Blood Purif"},{"key":"6337_CR35","doi-asserted-by":"publisher","first-page":"104598","DOI":"10.1016\/j.mvr.2023.104598","volume":"150","author":"A Garc\u00eda-Escobar","year":"2023","unstructured":"Garc\u00eda-Escobar A, Vera-Vera S, T\u00e9bar-M\u00e1rquez D, et al. Neutrophil-to-lymphocyte ratio an inflammatory biomarker, and prognostic marker in heart failure, cardiovascular disease and chronic inflammatory diseases: New insights for a potential predictor of anti-cytokine therapy responsiveness. Microvasc Res. 2023;150:104598.","journal-title":"Microvasc Res"},{"issue":"10444","key":"6337_CR36","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1016\/S0140-6736(24)00596-8","volume":"403","author":"K Chan","year":"2024","unstructured":"Chan K, Wahome E, Tsiachristas A, et al. Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: the ORFAN multicentre, longitudinal cohort study. Lancet. 2024;403(10444):2606\u201318.","journal-title":"Lancet"},{"issue":"1","key":"6337_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1161\/CIRCULATIONAHA.106.675355","volume":"116","author":"S Fox Caroline","year":"2007","unstructured":"Fox Caroline S, Massaro Joseph M, Udo H, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007;116(1):39\u201348.","journal-title":"Circulation"},{"key":"6337_CR38","doi-asserted-by":"publisher","first-page":"13855","DOI":"10.2147\/JIR.S547594","volume":"18","author":"S Gao","year":"2025","unstructured":"Gao S, Huang S, Liu X, Yu M, Li W. Significance of Residual Inflammatory Risk and Persistent Inflammation in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries. J Inflamm Res. 2025;18:13855\u201368.","journal-title":"J Inflamm Res"},{"issue":"19","key":"6337_CR39","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","volume":"383","author":"SM Nidorf","year":"2020","unstructured":"Nidorf SM, Fiolet ATL, Mosterd A, et al. Colchicine in Patients with Chronic Coronary Disease. N Engl J Med. 2020;383(19):1838\u201347.","journal-title":"N Engl J Med"},{"issue":"35","key":"6337_CR40","doi-asserted-by":"publisher","first-page":"e30285","DOI":"10.1097\/MD.0000000000030331","volume":"101","author":"S Luo","year":"2022","unstructured":"Luo S, Zhang J, Li B, Wu H. Predictive value of baseline C-reactive protein level in patients with stable coronary artery disease: A meta-analysis. Med (Baltim). 2022;101(35):e30285.","journal-title":"Med (Baltim)"},{"key":"6337_CR41","doi-asserted-by":"publisher","first-page":"9153673","DOI":"10.1155\/2016\/9153673","volume":"2016","author":"A Bonaventura","year":"2016","unstructured":"Bonaventura A, Mach F, Roth A, et al. Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis. Mediators Inflamm. 2016;2016:9153673.","journal-title":"Mediators Inflamm"},{"key":"6337_CR42","doi-asserted-by":"publisher","first-page":"1013501","DOI":"10.3389\/fcvm.2022.1013501","volume":"9","author":"S Liu","year":"2022","unstructured":"Liu S, Jiang H, Dhuromsingh M, Dai L, Jiang Y, Zeng H. Evaluation of C-reactive protein as predictor of adverse prognosis in acute myocardial infarction after percutaneous coronary intervention: A systematic review and meta-analysis from 18,715 individuals. Front Cardiovasc Med. 2022;9:1013501.","journal-title":"Front Cardiovasc Med"},{"issue":"12","key":"6337_CR43","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1056\/NEJMe1709904","volume":"377","author":"RA Harrington","year":"2017","unstructured":"Harrington RA. Targeting Inflammation in Coronary Artery Disease. N Engl J Med. 2017;377(12):1197\u20138.","journal-title":"N Engl J Med"},{"issue":"6","key":"6337_CR44","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1161\/01.CIR.0000115516.54550.B1","volume":"109","author":"BD Johnson","year":"2004","unstructured":"Johnson BD, Kip KE, Marroquin OC, et al. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women\u2019s Ischemia Syndrome Evaluation (WISE). Circulation. 2004;109(6):726\u201332.","journal-title":"Circulation"},{"issue":"5","key":"6337_CR45","doi-asserted-by":"publisher","first-page":"e0177684","DOI":"10.1371\/journal.pone.0177684","volume":"12","author":"A AlBadri","year":"2017","unstructured":"AlBadri A, Lai K, Wei J, et al. Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women\u2019s Ischemia Syndrome Evaluation (WISE). PLoS ONE. 2017;12(5):e0177684.","journal-title":"PLoS ONE"},{"issue":"24","key":"6337_CR46","first-page":"11832","volume":"27","author":"M Karasu","year":"2023","unstructured":"Karasu M, Karaca Y, Y\u0131ld\u0131r\u0131m E, Kobat MA, Er F. Neutrophil-to-albumin ratio: a promising tool for CAD assessment in non-ST elevation AMI. Eur Rev Med Pharmacol Sci. 2023;27(24):11832\u20139.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"6337_CR47","doi-asserted-by":"publisher","first-page":"37623","DOI":"10.1038\/s41598-025-21485-6","volume":"15","author":"TD Liu","year":"2025","unstructured":"Liu TD, Sun S, Zheng YY, Zhang JY. Aggregate index of systemic inflammation as a new prognostic marker in patients with coronary artery disease undergoing PCI. Sci Rep. 2025;15(1):37623.","journal-title":"Sci Rep"},{"key":"6337_CR48","doi-asserted-by":"crossref","unstructured":"Chang T, He Y, Ling Y et al. Relationship Between the Aggregate Index of Systemic Inflammation and the prognosis in Patients With CAD and CKD. Angiology. 2025:33197251338428.","DOI":"10.1177\/00033197251338428"},{"issue":"5","key":"6337_CR49","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/1756-185X.13309","volume":"21","author":"M Sanjadi","year":"2018","unstructured":"Sanjadi M, Rezvanie Sichanie Z, Totonchi H, Karami J, Rezaei R, Aslani S. Atherosclerosis and autoimmunity: a growing relationship. Int J Rheum Dis. 2018;21(5):908\u201321.","journal-title":"Int J Rheum Dis"},{"issue":"7","key":"6337_CR50","doi-asserted-by":"publisher","first-page":"619","DOI":"10.5551\/jat.10322","volume":"19","author":"M Wang","year":"2012","unstructured":"Wang M, Liu J, Ma C, et al. Synergistic association of serum albumin and globulin with coronary heart disease. J Atheroscler Thromb. 2012;19(7):619\u201332.","journal-title":"J Atheroscler Thromb"},{"key":"6337_CR51","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1600-0587.2012.07348.x","volume":"36","author":"C Dormann","year":"2013","unstructured":"Dormann C, Elith J, Bacher S, et al. Collinearity: A review of methods to deal with it and a simulation study evaluating their performance. Ecography. 2013;36:27\u201346.","journal-title":"Ecography"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06337-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06337-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06337-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:03:14Z","timestamp":1792630994000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06337-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6337"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06337-z","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by The Medical Ethics Committee of Hubei No.3 People\u2019s Hospital of Jianghan University (approval number: KY2025015). Given the retrospective design involving analysis of de-identified medical records and the absence of patient contact or intervention, the requirement for informed consent was waived by the ethics committee. All study procedures were conducted in accordance with the Declaration of Helsinki. This study adhered to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines for reporting cohort studies.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"961"}}